Form 8-K - Current report:
SEC Accession No. 0000200406-23-000037
Filing Date
2023-04-04
Accepted
2023-04-04 16:12:15
Documents
15
Period of Report
2023-04-04
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20230404.htm   iXBRL 8-K 35126
2 EX-99.1 a44238-kexhibit991.htm EX-99.1 15414
7 image_0.jpg GRAPHIC 8124
  Complete submission text file 0000200406-23-000037.txt   255721

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20230404.xsd EX-101.SCH 3331
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20230404_def.xml EX-101.DEF 16756
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20230404_lab.xml EX-101.LAB 34197
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20230404_pre.xml EX-101.PRE 17558
9 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20230404_htm.xml XML 8586
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 23797524
SIC: 2834 Pharmaceutical Preparations